We believe GLP-1 therapy is a serious medical intervention that requires baseline assessment, ongoing monitoring, and personalized optimization
Location & Dispensing: As a New York-based practice, our pricing may differ from other regions due to local healthcare regulations and pharmacy costs
Studies have shown that GLP-1 treatment significantly increases the expression levels of BTG2, Pdx1, and the insulin gene in pancreatic cells, indicating that GLP-1 positively regulates insulin gene expression through BTG2, thereby promoting insulin synthesis (Hwang et al., 2013)
The environment is very serene and comfortable
Maintaining good glycaemic control remains the primary therapeutic goal
Red blood cell storage time and transfusion: current practice, concerns and future perspectives